<DOC>
	<DOCNO>NCT00304187</DOCNO>
	<brief_summary>This study determine effectiveness antibiotic erythromycin enhance gastrointestinal function decrease frequency binge eat people bulimia nervosa .</brief_summary>
	<brief_title>Effectiveness Antibiotic Treatment Reducing Binge Eating Improving Digestive Function Bulimia Nervosa</brief_title>
	<detailed_description>Bulimia nervosa ( BN ) serious eat disorder characterize frequent uncontrolled eating binge . These binge often follow compensatory behavior , include follow : self-induced vomiting ; misuse laxative , diuretic , enema , medication induce purge ; fast ; excessive exercise . If leave untreated , BN lead many serious health issue : tooth decay ; irregular menstruation ; bowel damage ; constipation ; heart kidney disease ; intestinal damage ; puffiness , especially face finger ; increase hair growth face body ; mineral imbalance body . Although significant exist knowledge characteristic treatment BN , information need gastrointestinal ( GI ) function effect binge eat behavior . This study determine effectiveness antibiotic erythromycin enhance GI function decrease frequency binge eat people BN . Participants 8-week , double-blind study first undergo gastric empty GI hormone release test 1 day . Within 1 week complete pre-treatment test , participant randomly assign receive either erythromycin placebo 6 week . Upon medication assignment , participant meet psychiatrist receive assign medication . Participants receive medication weekly study visit . Medication dosage increase symptom improve , decreased adverse medication side effect report . A final day gastric empty GI hormone release testing , well routine blood test , take place Week 7 , 6 week medication treatment . Participants ' weight measure Weeks 1 , 4 , 7 . Participants also receive EKG 1 week upward dosage adjustment . Patients informed medication assignment Week 7 study visit , refer non-study clinician treatment . For information relate study , please see NCT00308776 NCT00307190 .</detailed_description>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia Nervosa</mesh_term>
	<mesh_term>Erythromycin</mesh_term>
	<mesh_term>Erythromycin Estolate</mesh_term>
	<mesh_term>Erythromycin Ethylsuccinate</mesh_term>
	<mesh_term>Erythromycin stearate</mesh_term>
	<criteria>Meets criteria bulimia nervosa Duration illness great 1 year Selfinduces vomit Weighs 80 % 120 % ideal weight Significant medical illness Current lifetime history schizophrenia , bipolar disorder , psychotic disorder , define American Psychiatric Association criterion Moderate severe depression , define score great 18 Hamilton Depression Scales Current diagnosis organic mental disorder , factitious disorder , malinger History personality disorder ( e.g. , schizotypal , borderline , antisocial ) might interfere assessment compliance study procedure At risk suicide Current psychotropic medication current medication affect GI function inhibit induce cytochrome three A gene expression Currently pregnant , lactate , plan become pregnant Drug alcohol abuse within 3 month prior study entry Abnormal EKG baseline 1 week follow upward dosage adjustment Anemia Known intolerance erythromycin , related antibiotic Abnormal result liver function test Electrolyte abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Binge-Eating Disorder</keyword>
</DOC>